LUMINITA BRENNAN: Open Payments
NPI 1124788625 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 39 payments from 15 companies in 2025. Trend: 2023 $834 · 2024 $739 · 2025 $916
Food & beverage: $916
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $122 |
| Neurocrine BioSciences, Inc. | 3 | $107 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Teva Pharmaceuticals USA, Inc. | 4 | $82 |
| Lundbeck LLC | 3 | $80 |
| Bausch Health US, LLC | 4 | $68 |
| Alkermes, Inc. | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Supernus Pharmaceuticals, Inc. | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
Products named: REXULTI, VRAYLAR, INGREZZA, AUSTEDO XR, APLENZIN, CAPLYTA, Qelbree, COBENFY.
Industry payments across IL — which companies pay providers there.
